The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?

by Sandra Gordon

Melanoma drug becomes first cell therapy approved to treat a solid tumor, and a new method for treating mesothelioma extended patient survival in a recent trial.

by Thomas Celona

Shirley Muñoz wants to use her experience as a younger lung cancer patient to break down barriers to care for her community through translation and advocacy.

by Cameron Walker

Studies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce benefits from these tactics.

by Cancer Research Catalyst

Researchers explore a try-everything approach to precision medicine, and physical activity may help ease cancer pain.

by Kevin McLaughlin

New research finds acupuncture and massage are associated with pain reduction for patients with advanced cancer.

by Laura Gesualdi-Gilmore

Patients and doctors urge researchers to study lower doses for cancer treatments, and the FDA faces criticism for not issuing a formaldehyde ban in hair straighteners.

by Marci A. Landsmann

Improving fitness linked to lower prostate cancer risk, and a study from Scotland finds no cervical cancer cases in women vaccinated before age 14.

by Eric Fitzsimmons

Study shines a light on the differences in outcomes between clinical trial patients with multiple myeloma and those receiving cancer treatment in their community.

by Sandra Gordon

Questions about screening for women with dense breast tissue, and the FDA asks drugmakers to add a warning to labels for CAR T-cell therapies.

by Thomas Celona